SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15716285
Source:
http://linkedlifedata.com/resource/pubmed/id/15716285
Search
Subject
(
57
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0167627
,
umls-concept:C0205178
,
umls-concept:C0264716
,
umls-concept:C1749467
pubmed:issue
11
pubmed:dateCreated
2005-5-23
pubmed:abstractText
Inflammatory cytokines may play a pathogenic role in heart failure (HF). CD40-CD40 ligand (CD40L) interactions are important in atherogenesis and based on its role in inflammation we sought to evaluate the role of CD40L in human HF.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8006263
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II Type 1 Receptor...
,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme...
,
http://linkedlifedata.com/resource/pubmed/chemical/CD40 Ligand
,
http://linkedlifedata.com/resource/pubmed/chemical/Captopril
,
http://linkedlifedata.com/resource/pubmed/chemical/Losartan
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0195-668X
pubmed:author
pubmed-author:AukrustPålP
,
pubmed-author:DamåsJan KJK
,
pubmed-author:DicksteinKennethK
,
pubmed-author:FrølandStig SSS
,
pubmed-author:GullestadLarsL
,
pubmed-author:KjekshusJohnJ
,
pubmed-author:OtterdalKariK
,
pubmed-author:UelandThorT
,
pubmed-author:YndestadArneA
pubmed:issnType
Print
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1101-7
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:15716285-Acute Disease
,
pubmed-meshheading:15716285-Adult
,
pubmed-meshheading:15716285-Aged
,
pubmed-meshheading:15716285-Angiotensin II Type 1 Receptor Blockers
,
pubmed-meshheading:15716285-Angiotensin-Converting Enzyme Inhibitors
,
pubmed-meshheading:15716285-CD40 Ligand
,
pubmed-meshheading:15716285-Captopril
,
pubmed-meshheading:15716285-Chronic Disease
,
pubmed-meshheading:15716285-Female
,
pubmed-meshheading:15716285-Heart Failure
,
pubmed-meshheading:15716285-Humans
,
pubmed-meshheading:15716285-Losartan
,
pubmed-meshheading:15716285-Male
,
pubmed-meshheading:15716285-Middle Aged
,
pubmed-meshheading:15716285-Myocardial Infarction
,
pubmed-meshheading:15716285-Treatment Outcome
pubmed:year
2005
pubmed:articleTitle
Soluble CD40 ligand in acute and chronic heart failure.
pubmed:affiliation
Research Institute for Internal Medicine, Rikshospitalet University Hospital, N-0027 Oslo, Norway. thor.ueland@klinmed.uio.no
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't